C3 Gene Functional Polymorphisms and C3 Serum Levels in Patients with Rheumatoid Arthritis

References

• Abrera-Abeleda MA, Nishimura C, Frees K, Jones M, Maga T, Katz LM, Smith RJH. 2011. Allelic variants of complement genes associated with dense deposit disease. J Am Soc Nephrol. 22(8):1551–59.
   PubMed Web of Science ®Google Scholar
• Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, et al. 2010. 2010 rheumatoid arthritis classification criteria. An American college of rheumatology/european league against rheumatism collaborative initiative. Arthritis Rheum. 62(9):2569–81. doi:https://doi.org/10.1002/art.27584.
   PubMed Web of Science ®Google Scholar
• Andrade FA, Lidani KCF, Catarino SJ, Messias-Reason IJ. 2017. Serine proteases in the lectin pathway of the complement system. Proteases Physiol Pathol. doi:https://doi.org/10.1007/978-981-10-2513-6_18
   Google Scholar
• Bemis EA, Norris JM, Seifert J, Frazer-Abel A, Okamoto Y, Feser ML, Holers VM. 2019. Complement and its environmental determinants in the progression of human rheumatoid arthritis. Mol Immunol. 112:256–65.
   PubMed Web of Science ®Google Scholar
• Biró E, Tak PP, Sturk A, Hack CE, Nieuwland R. 2008. Targeting complement in rheumatoid arthritis. Curr Rheumatol Rev. doi:https://doi.org/10.2174/157339708786263924
   Google Scholar
• Botto M, Fong KY, So AK, Koch C, Walport MJ. 1990. Molecular basis of polymorphisms of human complement component C3. J Exp Med. 172(4):1011–17.
   PubMed Web of Science ®Google Scholar
• Brodeur JP, Ruddy S, Schwartz LB, Moxley G. 2010. Synovial fluid levels of complement SC5b-9 and fragment Bb are elevated in patients with rheumatoid arthritis. Arthritis Rheum. 34(12):1531–37.
   Google Scholar
• Cardozo DM, Guelsin GA, Clementino SL, De Melo FC, Braga MA, De Souza C, Visentainer JEL. 2009. Extração de DNA a partir de sangue humano coagulado para aplicação nas técnicas de genotipagem de antígenos leucocitários humanos e de receptores semelhantes à imunoglobulina. Rev Soc Bras Med Trop. 42(6):651–56.
   PubMedGoogle Scholar
• Chen M, Daha MR, Kallenberg CGM 2010. The complement system in systemic autoimmune disease. J Autoimmun. 34(3). doi:https://doi.org/10.1016/j.jaut.2009.11.014
   Google Scholar
• Di Muzio G, Perricone C, Ballanti E, Kroegler B, Greco E, Novelli L, Perricone R. 2011. Complement system and rheumatoid arthritis: relationships with autoantibodies, serological, clinical features, and anti-TNF treatment. Int J Immunopathol Pharmacol. 24(2):357–66.
   PubMed Web of Science ®Google Scholar
• Doherty M, Richards N, Hornby J, Powell R. 1988. Relation between synovial fluid C3 degradation products and local joint inflammation in rheumatoid arthritis, osteoarthritis, and crystal associated arthropathy. Ann Rheum Dis. 47(3):190–97.
   PubMed Web of Science ®Google Scholar
• Farhud DD, Ananthakrishnan R, Walter H. 1972. Association between C′3 phenotypes and various diseases. Hum Genet. 17(1):57–60.
   Google Scholar
• Goedner I, Skare TL, Reason IT, Utiyama SR. 2011. Artrite reumatoide: uma visão atual Rheumatoid arthritis: a current view. Bras Patol Med Lab. 47(5):495–503. http://www.scielo.br/pdf/jbpml/v47n5/v47n5a02.pdf
   Google Scholar
• Harris CL, Williams AS, Linton SM, Morgan BP. 2002. Coupling complement regulators to immunoglobulin domains generates effective anti-complement reagents with extended half- life in vivo. Clin Exp Immunol. 129:198–207.
   PubMed Web of Science ®Google Scholar
• Heurich M, Martinez-Barricarte R, Francis NJ, Roberts DL, Cordoba SR, Morgan BP, Harris CL. 2011. Common polymorphisms in C3, factor B, and factor H collaborate to determine systemic complement activity and disease risk. Proc Natl Acad Sci. 108(21):8761–66.
   PubMed Web of Science ®Google Scholar
• Holers VM, Banda NK. 2018. Complement in the initiation and evolution of rheumatoid arthritis. Front Immunol. 9. doi:https://doi.org/10.3389/fimmu.2018.01057
   Google Scholar
• Linton SM, Williams AS, Dodd I, Smith R, Williams BD, Morgan BP. 2000. Therapeutic efficacy of a novel membrane-targeted complement regulator in antigen-induced arthritis in the rat. Arthritis Rheum. 43:2590–97.
   PubMedGoogle Scholar
• Makinde VA, Senaldi G, Jawad ASM, Berry H, Vergani D. 1989. Reflection of disease activity in rheumatoid arthritis by indices of activation of the classical complement pathway. Ann Rheum Dis. 48(4):302–06.
   PubMed Web of Science ®Google Scholar
• Mizuno M, Nishikawa K, Morgan BP, Matsuo S. 2000. Comparison of the suppressive effects of soluble CR1 and C5a receptor antagonist in acute arthritis induced in rats by blocking of CD59. Clin Exp Immunol. 119:368–75.
   PubMed Web of Science ®Google Scholar
• Mödinger Y, Teixeira G, Neidlinger-Wilke C, Ignatius A. 2018. Role of the complement system in the response to orthopedic biomaterials. Int J Mol Sci. 19(11):3367.
   Web of Science ®Google Scholar
• Nagayoshi BA, Lourenção LG, Kobayase YNS, Paula PM, Miyazaki MC. 2018. Rheumatoid arthritis: profile of patients and burden of caregivers. Revista Brasileira De Geriatria E Gerontologia. 21(1):44–52.
   Google Scholar
• Nass FR, Skare TL, Goeldner I, Nisihara R, Messias-Reason IJ, Utiyama SRR. 2015. Association of complement factor B allotypes and serum biomarkers in rheumatoid arthritis patients and their relatives. Int J Immunogenet. 42(6):439–44.
   PubMed Web of Science ®Google Scholar
• Neumann E, Barnum SR, Tarner IH, Echols J, Fleck M, Judex M, Müller-Ladner U. 2002. Local production of complement proteins in rheumatoid arthritis synovium. Arthritis Rheum. 46(4):934–45.
   PubMed Web of Science ®Google Scholar
• Nisar H, Pasha U, Mirza MU, Abid R, Hanif K, Kadarmideen HN, Sadaf S. 2020. Impact of IL-17F 7488T/C functional polymorphism on progressive rheumatoid arthritis: novel insight from the molecular dynamic simulations. Immunol Invest. 1–11. doi:https://doi.org/10.1080/08820139.2020.1775642
   Google Scholar
• Okroj M, Heinegård D, Holmdahl R, Blom AM. 2007. Rheumatoid arthritis and the complement system. Ann Med. 39(7):517–30.
   PubMed Web of Science ®Google Scholar
• Olmez U, Garred P, Mollnes TE, Harboe M, Berntzen HB, Munthe E. 1991. C3 activation products, C3 containing immune complexes, the terminal complement complex and native C9 in patients with rheumatoid arthritis. Scand J Rheumatol. 20(3):183–89. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/2068540
   PubMed Web of Science ®Google Scholar
• Paoliello-Paschoalato AB, Marchi LF, de Andrade MF, Kabeya LM, Donadi EA, Lucisano-Valim YM. 2015. Fc γ and complement receptors and complement proteins in neutrophil activation in rheumatoid arthritis: contribution to pathogenesis and progression and modulation by natural products. Evidence-Based Complementary Altern Med. 2015:1–22. https://doi.10.1155/2015/429878
   Web of Science ®Google Scholar
• Paun CC, Lechanteur YTE, Groenewoud JMM, Altay L, Schick T, de Daha MR, Jong EK. 2016. A novel complotype combination associates with age-related macular degeneration and high complement activation levels in vivo. Sci Rep. 6(1):26568.
   PubMedGoogle Scholar
• Perrin LH, Zubler RH, Nydegger EU, Lambert PH, Miescher PA. 1977. Correlation between levels of breakdown products of C3, C4, and properdin factor b in synovial fluids from patients with rheumatoid arthritis. Arthritis Rheum. 20(2):647–52.
   PubMedGoogle Scholar
• Ricklin D, Reis ES, Mastellos DC, Gros P, Lambris JD. 2016. Complement component C3 - the “Swiss Army Knife” of innate immunity and host defense. Immunol Rev. 274(1):33–58.
   PubMed Web of Science ®Google Scholar
• Rodriguez E, Nan R, Li K, Gor J, Perkins SJ. 2015. A revised mechanism for the activation of complement C3 to C3b: A molecular explanation of a disease-associated polymorphism. J Biol Chem. 290(4):2334–50.
   PubMed Web of Science ®Google Scholar
• Roostaei T, Sadaghiani S, Mashhadi R, Falahatian M, Mohamadi E, Javadian N, Sahraian MA. 2019. Convergent effects of a functional C3 variant on brain atrophy, demyelination, and cognitive impairment in multiple sclerosis. Multiple Sclerosis J. 25(4):532–40.
   PubMed Web of Science ®Google Scholar
• Scodeler GC, Resende FCBE. 2017. Avanços e perspectivas dos estudos da artrite reumatoide. Revista Eletrônica Acervo Saúde, Esp. 6:S386–S391. doi:https://doi.org/10.25248/REAS-S40_2017.
   Google Scholar
• Song H, Qiao F, Atkinson C, Holers VM, Tomlinson S. 2007. A complement C3 inhibitor specifically targeted to sites of complement activation effectively ameliorates collagen-induced arthritis in DBA/1J mice. J Immunol. 179:7860–67.
   PubMed Web of Science ®Google Scholar
• Swaak AJ, Van Rooyen A, Planten O, Han H, Hattink O, Hack E. 1987. An analysis of the levels of complement components in the synovial fluid in rheumatic diseases. Clin Rheumatol. 6(3):350–57.
   PubMed Web of Science ®Google Scholar
• Törn C, Liu X, Hagopian W, Å L, Simell O, Rewers M, Krischer J. 2016. Complement gene variants in relation to autoantibodies to beta cell specific antigens and type 1 diabetes in the TEDDY study OPEN. Sci Rep. doi:https://doi.org/10.1038/srep27887
   Google Scholar
• Utiyama SR, Reason R, ITde M, Kotze LMda S. 2004. O sistema complemento nas doenças: genética e patogenia. Rev Bras Reumatol. 44(4):277–86.
   Google Scholar
• Viatte S, Plant D, Han B, Fu B, Yarwood A, Barton A. 2015. Association of HLA-DRB1 haplotypes with rheumatoid arthritis severity, mortality, and treatment response. JAMA. 313(16):1645–56.
   PubMed Web of Science ®Google Scholar
• Zhang MX, Zhao XF, Ren YC, Geng TT, Yang H, Feng T, Chen C. 2015. Association between a functional genetic polymorphism (rs2230199) and age-related macular degeneration risk: a meta-analysis. Genet Mol Res. 14(4):12567–76.
   PubMed Web of Science ®Google Scholar